Livdelzi
Payments companies reported to CMS as associated with Livdelzi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Livdelzi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Livdelzi
These are the largest totals companies reported as associated with Livdelzi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ilan Weisberg | New York, NY | Gastroenterology (Internal Medicine) | $102,284.92 |
| Shady Guirguis | Orlando, FL | Hepatology | $97,069.87 |
| Stuart Gordon | Detroit, MI | Gastroenterology (Internal Medicine) | $94,928.54 |
| John Vierling | Houston, TX | Gastroenterology (Internal Medicine) | $78,894.62 |
| Adam Peyton | Allentown, PA | Gastroenterology (Internal Medicine) | $78,125.68 |
| Apurva Modi | Rockville, MD | Gastroenterology (Internal Medicine) | $76,689.32 |
| Terry Box | Salt Lake City, UT | Gastroenterology (Internal Medicine) | $73,768.32 |
| Douglas Dieterich | New York, NY | Hepatology | $66,856.22 |
| Gia Landry | Baton Rouge, LA | Gastroenterology (Internal Medicine) | $65,468.10 |
| Steven Flamm | Chicago, IL | Gastroenterology (Internal Medicine) | $63,451.19 |
Prescribed Livdelzi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.